Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
IL |
|
Axalta Coating Systems Ltd
NYSE:AXTA
|
US |
|
S
|
Swiss Re AG
XHAM:SR9
|
CH |
|
M
|
MSCI Inc
F:3HM
|
US |
|
I
|
ITV PLC
DUS:IJ7
|
UK |
|
M
|
Mitsubishi Heavy Industries Ltd
XMUN:MIH
|
JP |
|
S
|
Sumitomo Electric Industries Ltd
DUS:SMO
|
JP |
|
D
|
Deutsche Telekom AG
BMV:DTEN
|
DE |
|
Bit Digital Inc
NASDAQ:BTBT
|
US |
|
Telefonica SA
MAD:TEF
|
ES |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TEVA's stock price target?
Not Available
TEVA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is 7%.
What is the Pre-Tax Income forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
56%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 56%.
What is the Net Income forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 8 years is 20%.
